J. Borkowski

The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters

C. Mondadori, T. Ducret, J. Borkowski, 1989, Behavioural Brain Research.

Effects of Oxiracetam on Learning and Memory in Animals: Comparison with Piracetam

W. Classen, C. Mondadori, T. Ducret, 1986, Clinical neuropharmacology.

The GABAB receptor antagonist CGP 36 742 and the nootropic oxiracetam facilitate the formation of long-term memory

C. Mondadori, H. Möbius, J. Borkowski, 1996, Behavioural Brain Research.

Involvement of a steroidal component in the mechanism of action of piracetam-like nootropics

C. Mondadori, A. Bhatnagar, J. Borkowski, 1990, Brain Research.

Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory.

B. Hengerer, C. Mondadori, T. Ducret, 1994, Proceedings of the National Academy of Sciences of the United States of America.

How long does ‘memory consolidation’ take? New compounds can improve retention performance, even if administered up to 24 hours after the learning experience

C. Mondadori, T. Ducret, J. Borkowski, 1991, Brain Research.

Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37 849, and strychnine in mice

C. Mondadori, A. Racine, B. Hengerer, 2005, Psychopharmacology.

The memory-facilitating effects of the competitive NMDA-receptor antagonist CGP 37849 are steroid-sensitive, whereas its memory-impairing effects are not

C. Gentsch, C. Mondadori, J. Borkowski, 1996, Psychopharmacology.